Crossmark

Simvastatin improves olanzapine-induced dyslipidemia in rats through inhibiting hepatic mTOR signaling pathway

Published Online: 2019-02-06

Published Print: 2019-08

Authors

Liu, Xue-mei

Zhao, Xiao-min

Deng, Chao

Zeng, Yan-ping

Hu, Chang-hua
License Information

Text and Data Mining valid from 2019-02-06

Version of Record valid from 2019-02-06
More Information

Article History

Received: 29 September 2018

Accepted: 7 January 2019

First Online: 6 February 2019

Competing interests

: The authors declare no competing interests.

Document is current